Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · IEX Real-Time Price · USD
9.80
-0.01 (-0.10%)
At close: Jul 19, 2024, 4:00 PM
10.03
+0.23 (2.35%)
Pre-market: Jul 22, 2024, 7:05 AM EDT
Travere Therapeutics Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for TVTX stock have an average target of 15.36, with a low estimate of 9.00 and a high estimate of 27. The average target predicts an increase of 56.73% from the current stock price of 9.80.
Analyst Consensus: Buy
* Price targets were last updated on May 7, 2024.
Analyst Ratings
The average analyst rating for TVTX stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 4 | 4 | 4 | 4 |
| Buy | 6 | 5 | 5 | 5 | 5 | 4 |
| Hold | 4 | 5 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 14 | 14 | 14 | 14 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +93.88% | May 7, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $15 → $18 | Strong Buy | Maintains | $15 → $18 | +83.67% | May 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $17 → $19 | Strong Buy | Maintains | $17 → $19 | +93.88% | Apr 24, 2024 |
| Wedbush | Wedbush | Buy Reiterates $13 | Buy | Reiterates | $13 | +32.65% | Apr 17, 2024 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 27, 2024 |
Financial Forecast
Revenue This Year
220.88M
from 145.24M
Increased by 52.08%
Revenue Next Year
331.06M
from 220.88M
Increased by 49.88%
EPS This Year
-3.76
from -1.50
EPS Next Year
-1.58
from -3.76
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 265.7M | 538.3M | 680.5M | 726.6M | 921.9M |
| Avg | 220.9M | 331.1M | 450.7M | 494.5M | 617.4M |
| Low | 180.7M | 257.0M | 298.1M | 175.7M | 293.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 82.9% | 143.7% | 105.6% | 61.2% | 86.4% |
| Avg | 52.1% | 49.9% | 36.1% | 9.7% | 24.9% |
| Low | 24.4% | 16.4% | -10.0% | -61.0% | -40.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.71 | 0.26 | 2.07 | 0.79 | 1.46 |
| Avg | -3.76 | -1.58 | 0.08 | 0.31 | 0.63 |
| Low | -4.53 | -2.31 | -1.18 | -0.28 | 0.05 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 845.3% | 369.1% |
| Avg | - | - | - | 273.5% | 104.1% |
| Low | - | - | - | - | -84.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.